 
                Lv73
4960 积分 2021-05-10 加入
 CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression
                                            13小时前
                                            已完结
CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression
                                            13小时前
                                            已完结
                                         Risks of Progression Following Early Androgen Deprivation Therapy for Biochemical Recurrence After Radical Prostatectomy
                                            1天前
                                            求助中
Risks of Progression Following Early Androgen Deprivation Therapy for Biochemical Recurrence After Radical Prostatectomy
                                            1天前
                                            求助中
                                         Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
                                            15天前
                                            已完结
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
                                            15天前
                                            已完结
                                         Applying a Process Improvement Approach to Optimize Operating Room Turnover in Urology
                                            21天前
                                            已完结
Applying a Process Improvement Approach to Optimize Operating Room Turnover in Urology
                                            21天前
                                            已完结
                                         Prevalence of urolithiasis in China: a systematic review and meta‐analysis
                                            2个月前
                                            已完结
Prevalence of urolithiasis in China: a systematic review and meta‐analysis
                                            2个月前
                                            已完结
                                         Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
                                            2个月前
                                            已完结
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
                                            2个月前
                                            已完结
                                         Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
                                            2个月前
                                            已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
                                            2个月前
                                            已完结
                                         Targeting the tumour cell surface in advanced prostate cancer
                                            2个月前
                                            已完结
Targeting the tumour cell surface in advanced prostate cancer
                                            2个月前
                                            已完结
                                         STEAP1: a promising target in prostate cancer therapy
                                            2个月前
                                            已完结
STEAP1: a promising target in prostate cancer therapy
                                            2个月前
                                            已完结
                                         Chimeric antigen receptor-engineered (CAR)-T cell therapy for metastatic prostate cancer
                                            2个月前
                                            已完结
Chimeric antigen receptor-engineered (CAR)-T cell therapy for metastatic prostate cancer
                                            2个月前
                                            已完结